企業プロフィール
Celyad 株価・ニュース・カタリスト
- ティッカー:
- CYAD
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Belgium and traded in the U
株価変動の要因
CYAD の終値変動に関する情報は現在取得できません。
企業概要
事業概要
Celyad was a cell-therapy company focused on CAR-T and immune-cell engineering before becoming a historical ticker. Its narrative centered on trying to develop next-generation allogeneic cell therapies for cancer.
所在地とセクター分類
Celyad was headquartered in Belgium and traded in the U.S. market. It sat in cell therapy and oncology biotechnology.
ビジネスモデルの特徴
The company depended on translational progress, manufacturing feasibility, and capital support in a difficult cell-therapy market. Investors historically watched early data and the company's ability to keep its platform alive.
バイオ業界での位置付け
Celyad is a historical cell-therapy biotech name. It belongs to the category of platform companies that were highly dependent on scientific validation and financing.
今後のカタリスト
- Celyad’s catalysts are its CAR-T and cell-therapy assets, plus any strategic update that clarifies what remains after earlier setbacks. The market is watching for a cleaner path more than broad optionality.
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。